
Corteva's stock has fallen about one-third since mid-October due to economic pressures in Latin America, especially Brazil's high inflation and interest rates, which have reduced farmer credit and led to a 28% drop in Latin American sales in Q3. Despite this, Corteva's strong crop-protection business, extensive patent portfolio, and $11 billion pipeline position it well for future growth. The stock trades at roughly 10 times forward earnings and is expected to deliver an estimated 10% annualized return, excluding potential gains from rising soybean prices. The company's need for continuous innovation in biological products remains a key factor for sustained success.
Corteva's stock is trading at USD 8.37 on Pluang as of Nov 19, 2026 15:01 WIB, showing a slight 0.12% increase in the last day. The company has a market cap of $5.89 billion and a dividend yield of 6.69% on the platform. Despite recent challenges, Pluang users are predominantly selling Corteva shares, with 95% of order activity marked as sell.